nodes	percent_of_prediction	percent_of_DWPC	metapath
Epoprostenol—CYP2C9—Zileuton—asthma	0.0546	0.173	CbGbCtD
Epoprostenol—CYP2C9—Zafirlukast—asthma	0.0481	0.153	CbGbCtD
Epoprostenol—CYP2C9—Arformoterol—asthma	0.0465	0.147	CbGbCtD
Epoprostenol—CYP2C9—Formoterol—asthma	0.0465	0.147	CbGbCtD
Epoprostenol—CYP2C9—Theophylline—asthma	0.0371	0.118	CbGbCtD
Epoprostenol—CYP2C9—Loratadine—asthma	0.0352	0.112	CbGbCtD
Epoprostenol—CYP2C9—Montelukast—asthma	0.0352	0.112	CbGbCtD
Epoprostenol—CYP2C9—Dexamethasone—asthma	0.0122	0.0386	CbGbCtD
Epoprostenol—PTGIS—respiratory system—asthma	0.00719	0.126	CbGeAlD
Epoprostenol—PTGIS—smooth muscle tissue—asthma	0.00579	0.102	CbGeAlD
Epoprostenol—PTGIS—cardiovascular system—asthma	0.00551	0.0967	CbGeAlD
Epoprostenol—P2RY12—epithelium—asthma	0.00541	0.095	CbGeAlD
Epoprostenol—P2RY12—cardiovascular system—asthma	0.00496	0.0871	CbGeAlD
Epoprostenol—PTGIS—adrenal gland—asthma	0.00436	0.0765	CbGeAlD
Epoprostenol—PTGIR—respiratory system—asthma	0.00413	0.0725	CbGeAlD
Epoprostenol—PTGIS—lung—asthma	0.00382	0.0671	CbGeAlD
Epoprostenol—PTGIR—epithelium—asthma	0.00345	0.0606	CbGeAlD
Epoprostenol—PTGIR—smooth muscle tissue—asthma	0.00333	0.0584	CbGeAlD
Epoprostenol—PTGIR—cardiovascular system—asthma	0.00316	0.0556	CbGeAlD
Epoprostenol—PTGIR—adrenal gland—asthma	0.0025	0.0439	CbGeAlD
Epoprostenol—PTGIR—lung—asthma	0.00219	0.0385	CbGeAlD
Epoprostenol—CYP2C9—cardiovascular system—asthma	0.00113	0.0199	CbGeAlD
Epoprostenol—Acute coronary syndrome—Prednisone—asthma	0.000104	0.000296	CcSEcCtD
Epoprostenol—Myocardial infarction—Prednisone—asthma	0.000103	0.000295	CcSEcCtD
Epoprostenol—Dizziness—Budesonide—asthma	0.000103	0.000295	CcSEcCtD
Epoprostenol—Vomiting—Salbutamol—asthma	0.000103	0.000292	CcSEcCtD
Epoprostenol—Rash—Salbutamol—asthma	0.000102	0.00029	CcSEcCtD
Epoprostenol—Syncope—Prednisolone—asthma	0.000102	0.00029	CcSEcCtD
Epoprostenol—Dermatitis—Salbutamol—asthma	0.000102	0.00029	CcSEcCtD
Epoprostenol—Nausea—Arformoterol—asthma	0.000102	0.000289	CcSEcCtD
Epoprostenol—Nausea—Formoterol—asthma	0.000102	0.000289	CcSEcCtD
Epoprostenol—Headache—Salbutamol—asthma	0.000101	0.000288	CcSEcCtD
Epoprostenol—Back pain—Triamcinolone—asthma	0.000101	0.000287	CcSEcCtD
Epoprostenol—Loss of consciousness—Prednisolone—asthma	9.98e-05	0.000284	CcSEcCtD
Epoprostenol—Nausea—Montelukast—asthma	9.95e-05	0.000283	CcSEcCtD
Epoprostenol—Vomiting—Budesonide—asthma	9.95e-05	0.000283	CcSEcCtD
Epoprostenol—Syncope—Hydrocortisone—asthma	9.94e-05	0.000283	CcSEcCtD
Epoprostenol—Angiopathy—Betamethasone—asthma	9.87e-05	0.000281	CcSEcCtD
Epoprostenol—Angiopathy—Dexamethasone—asthma	9.87e-05	0.000281	CcSEcCtD
Epoprostenol—Rash—Budesonide—asthma	9.86e-05	0.000281	CcSEcCtD
Epoprostenol—Dermatitis—Budesonide—asthma	9.86e-05	0.000281	CcSEcCtD
Epoprostenol—Headache—Budesonide—asthma	9.8e-05	0.000279	CcSEcCtD
Epoprostenol—Loss of consciousness—Hydrocortisone—asthma	9.74e-05	0.000277	CcSEcCtD
Epoprostenol—Bradycardia—Prednisone—asthma	9.65e-05	0.000275	CcSEcCtD
Epoprostenol—Nausea—Salbutamol—asthma	9.59e-05	0.000273	CcSEcCtD
Epoprostenol—Haemoglobin—Prednisone—asthma	9.52e-05	0.000271	CcSEcCtD
Epoprostenol—Haemorrhage—Prednisone—asthma	9.48e-05	0.00027	CcSEcCtD
Epoprostenol—Myalgia—Hydrocortisone—asthma	9.44e-05	0.000269	CcSEcCtD
Epoprostenol—Anxiety—Hydrocortisone—asthma	9.41e-05	0.000268	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	9.37e-05	0.000267	CcSEcCtD
Epoprostenol—Syncope—Triamcinolone—asthma	9.36e-05	0.000267	CcSEcCtD
Epoprostenol—Syncope—Methylprednisolone—asthma	9.34e-05	0.000266	CcSEcCtD
Epoprostenol—Connective tissue disorder—Prednisone—asthma	9.31e-05	0.000265	CcSEcCtD
Epoprostenol—Nausea—Budesonide—asthma	9.29e-05	0.000265	CcSEcCtD
Epoprostenol—Anaphylactic shock—Prednisolone—asthma	9.26e-05	0.000264	CcSEcCtD
Epoprostenol—Oedema—Prednisolone—asthma	9.26e-05	0.000264	CcSEcCtD
Epoprostenol—Loss of consciousness—Triamcinolone—asthma	9.18e-05	0.000261	CcSEcCtD
Epoprostenol—Loss of consciousness—Methylprednisolone—asthma	9.15e-05	0.000261	CcSEcCtD
Epoprostenol—Shock—Prednisolone—asthma	9.11e-05	0.000259	CcSEcCtD
Epoprostenol—Cough—Triamcinolone—asthma	9.11e-05	0.000259	CcSEcCtD
Epoprostenol—Anaphylactic shock—Hydrocortisone—asthma	9.05e-05	0.000258	CcSEcCtD
Epoprostenol—Oedema—Hydrocortisone—asthma	9.05e-05	0.000258	CcSEcCtD
Epoprostenol—Tachycardia—Prednisolone—asthma	9.04e-05	0.000257	CcSEcCtD
Epoprostenol—Infection—Hydrocortisone—asthma	8.99e-05	0.000256	CcSEcCtD
Epoprostenol—Hyperhidrosis—Prednisolone—asthma	8.96e-05	0.000255	CcSEcCtD
Epoprostenol—Shock—Hydrocortisone—asthma	8.9e-05	0.000253	CcSEcCtD
Epoprostenol—Myalgia—Triamcinolone—asthma	8.89e-05	0.000253	CcSEcCtD
Epoprostenol—Nervous system disorder—Hydrocortisone—asthma	8.87e-05	0.000253	CcSEcCtD
Epoprostenol—Myalgia—Methylprednisolone—asthma	8.87e-05	0.000252	CcSEcCtD
Epoprostenol—Arthralgia—Methylprednisolone—asthma	8.87e-05	0.000252	CcSEcCtD
Epoprostenol—Anxiety—Methylprednisolone—asthma	8.84e-05	0.000252	CcSEcCtD
Epoprostenol—Tachycardia—Hydrocortisone—asthma	8.83e-05	0.000251	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	8.81e-05	0.000251	CcSEcCtD
Epoprostenol—Flushing—Prednisone—asthma	8.79e-05	0.00025	CcSEcCtD
Epoprostenol—Skin disorder—Hydrocortisone—asthma	8.79e-05	0.00025	CcSEcCtD
Epoprostenol—Hyperhidrosis—Hydrocortisone—asthma	8.75e-05	0.000249	CcSEcCtD
Epoprostenol—Dry mouth—Triamcinolone—asthma	8.69e-05	0.000247	CcSEcCtD
Epoprostenol—Anorexia—Hydrocortisone—asthma	8.62e-05	0.000246	CcSEcCtD
Epoprostenol—Angiopathy—Prednisone—asthma	8.6e-05	0.000245	CcSEcCtD
Epoprostenol—Confusional state—Methylprednisolone—asthma	8.57e-05	0.000244	CcSEcCtD
Epoprostenol—Oedema—Triamcinolone—asthma	8.52e-05	0.000243	CcSEcCtD
Epoprostenol—Anaphylactic shock—Triamcinolone—asthma	8.52e-05	0.000243	CcSEcCtD
Epoprostenol—Anaphylactic shock—Methylprednisolone—asthma	8.5e-05	0.000242	CcSEcCtD
Epoprostenol—Syncope—Betamethasone—asthma	8.49e-05	0.000242	CcSEcCtD
Epoprostenol—Syncope—Dexamethasone—asthma	8.49e-05	0.000242	CcSEcCtD
Epoprostenol—Infection—Triamcinolone—asthma	8.46e-05	0.000241	CcSEcCtD
Epoprostenol—Hypotension—Hydrocortisone—asthma	8.45e-05	0.000241	CcSEcCtD
Epoprostenol—Infection—Methylprednisolone—asthma	8.45e-05	0.00024	CcSEcCtD
Epoprostenol—Shock—Triamcinolone—asthma	8.38e-05	0.000239	CcSEcCtD
Epoprostenol—Insomnia—Prednisolone—asthma	8.38e-05	0.000239	CcSEcCtD
Epoprostenol—Shock—Methylprednisolone—asthma	8.36e-05	0.000238	CcSEcCtD
Epoprostenol—Nervous system disorder—Methylprednisolone—asthma	8.34e-05	0.000237	CcSEcCtD
Epoprostenol—Loss of consciousness—Dexamethasone—asthma	8.33e-05	0.000237	CcSEcCtD
Epoprostenol—Loss of consciousness—Betamethasone—asthma	8.33e-05	0.000237	CcSEcCtD
Epoprostenol—Paraesthesia—Prednisolone—asthma	8.32e-05	0.000237	CcSEcCtD
Epoprostenol—Tachycardia—Triamcinolone—asthma	8.31e-05	0.000237	CcSEcCtD
Epoprostenol—Mental disorder—Prednisone—asthma	8.3e-05	0.000236	CcSEcCtD
Epoprostenol—Tachycardia—Methylprednisolone—asthma	8.3e-05	0.000236	CcSEcCtD
Epoprostenol—Skin disorder—Methylprednisolone—asthma	8.26e-05	0.000235	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Hydrocortisone—asthma	8.24e-05	0.000235	CcSEcCtD
Epoprostenol—Hyperhidrosis—Triamcinolone—asthma	8.24e-05	0.000234	CcSEcCtD
Epoprostenol—Hyperhidrosis—Methylprednisolone—asthma	8.22e-05	0.000234	CcSEcCtD
Epoprostenol—Insomnia—Hydrocortisone—asthma	8.18e-05	0.000233	CcSEcCtD
Epoprostenol—Paraesthesia—Hydrocortisone—asthma	8.12e-05	0.000231	CcSEcCtD
Epoprostenol—Myalgia—Betamethasone—asthma	8.06e-05	0.00023	CcSEcCtD
Epoprostenol—Myalgia—Dexamethasone—asthma	8.06e-05	0.00023	CcSEcCtD
Epoprostenol—Anxiety—Dexamethasone—asthma	8.04e-05	0.000229	CcSEcCtD
Epoprostenol—Anxiety—Betamethasone—asthma	8.04e-05	0.000229	CcSEcCtD
Epoprostenol—Dyspepsia—Hydrocortisone—asthma	7.96e-05	0.000227	CcSEcCtD
Epoprostenol—Hypotension—Methylprednisolone—asthma	7.94e-05	0.000226	CcSEcCtD
Epoprostenol—Pain—Prednisolone—asthma	7.92e-05	0.000226	CcSEcCtD
Epoprostenol—Decreased appetite—Hydrocortisone—asthma	7.87e-05	0.000224	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Hydrocortisone—asthma	7.81e-05	0.000222	CcSEcCtD
Epoprostenol—Fatigue—Hydrocortisone—asthma	7.8e-05	0.000222	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Triamcinolone—asthma	7.76e-05	0.000221	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Methylprednisolone—asthma	7.74e-05	0.00022	CcSEcCtD
Epoprostenol—Pain—Hydrocortisone—asthma	7.74e-05	0.00022	CcSEcCtD
Epoprostenol—Oedema—Dexamethasone—asthma	7.73e-05	0.00022	CcSEcCtD
Epoprostenol—Anaphylactic shock—Betamethasone—asthma	7.73e-05	0.00022	CcSEcCtD
Epoprostenol—Anaphylactic shock—Dexamethasone—asthma	7.73e-05	0.00022	CcSEcCtD
Epoprostenol—Oedema—Betamethasone—asthma	7.73e-05	0.00022	CcSEcCtD
Epoprostenol—Insomnia—Triamcinolone—asthma	7.71e-05	0.000219	CcSEcCtD
Epoprostenol—Insomnia—Methylprednisolone—asthma	7.69e-05	0.000219	CcSEcCtD
Epoprostenol—Infection—Dexamethasone—asthma	7.68e-05	0.000219	CcSEcCtD
Epoprostenol—Infection—Betamethasone—asthma	7.68e-05	0.000219	CcSEcCtD
Epoprostenol—Paraesthesia—Triamcinolone—asthma	7.65e-05	0.000218	CcSEcCtD
Epoprostenol—Paraesthesia—Methylprednisolone—asthma	7.63e-05	0.000217	CcSEcCtD
Epoprostenol—Anaemia—Prednisone—asthma	7.62e-05	0.000217	CcSEcCtD
Epoprostenol—Shock—Betamethasone—asthma	7.61e-05	0.000217	CcSEcCtD
Epoprostenol—Shock—Dexamethasone—asthma	7.61e-05	0.000217	CcSEcCtD
Epoprostenol—Dyspnoea—Triamcinolone—asthma	7.6e-05	0.000216	CcSEcCtD
Epoprostenol—Nervous system disorder—Dexamethasone—asthma	7.58e-05	0.000216	CcSEcCtD
Epoprostenol—Nervous system disorder—Betamethasone—asthma	7.58e-05	0.000216	CcSEcCtD
Epoprostenol—Agitation—Prednisone—asthma	7.58e-05	0.000216	CcSEcCtD
Epoprostenol—Thrombocytopenia—Dexamethasone—asthma	7.57e-05	0.000215	CcSEcCtD
Epoprostenol—Thrombocytopenia—Betamethasone—asthma	7.57e-05	0.000215	CcSEcCtD
Epoprostenol—Tachycardia—Dexamethasone—asthma	7.54e-05	0.000215	CcSEcCtD
Epoprostenol—Tachycardia—Betamethasone—asthma	7.54e-05	0.000215	CcSEcCtD
Epoprostenol—Dyspepsia—Triamcinolone—asthma	7.5e-05	0.000214	CcSEcCtD
Epoprostenol—Dyspepsia—Methylprednisolone—asthma	7.48e-05	0.000213	CcSEcCtD
Epoprostenol—Hyperhidrosis—Dexamethasone—asthma	7.47e-05	0.000213	CcSEcCtD
Epoprostenol—Hyperhidrosis—Betamethasone—asthma	7.47e-05	0.000213	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Hydrocortisone—asthma	7.4e-05	0.000211	CcSEcCtD
Epoprostenol—Syncope—Prednisone—asthma	7.4e-05	0.000211	CcSEcCtD
Epoprostenol—Anorexia—Dexamethasone—asthma	7.37e-05	0.00021	CcSEcCtD
Epoprostenol—Anorexia—Betamethasone—asthma	7.37e-05	0.00021	CcSEcCtD
Epoprostenol—Urticaria—Prednisolone—asthma	7.36e-05	0.00021	CcSEcCtD
Epoprostenol—Fatigue—Triamcinolone—asthma	7.35e-05	0.000209	CcSEcCtD
Epoprostenol—Fatigue—Methylprednisolone—asthma	7.33e-05	0.000209	CcSEcCtD
Epoprostenol—Pain—Triamcinolone—asthma	7.29e-05	0.000207	CcSEcCtD
Epoprostenol—Loss of consciousness—Prednisone—asthma	7.25e-05	0.000206	CcSEcCtD
Epoprostenol—Hypotension—Betamethasone—asthma	7.22e-05	0.000206	CcSEcCtD
Epoprostenol—Hypotension—Dexamethasone—asthma	7.22e-05	0.000206	CcSEcCtD
Epoprostenol—Urticaria—Hydrocortisone—asthma	7.19e-05	0.000205	CcSEcCtD
Epoprostenol—Abdominal pain—Hydrocortisone—asthma	7.15e-05	0.000204	CcSEcCtD
Epoprostenol—Body temperature increased—Hydrocortisone—asthma	7.15e-05	0.000204	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Dexamethasone—asthma	7.04e-05	0.000201	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Betamethasone—asthma	7.04e-05	0.000201	CcSEcCtD
Epoprostenol—Arthralgia—Prednisone—asthma	7.02e-05	0.0002	CcSEcCtD
Epoprostenol—Myalgia—Prednisone—asthma	7.02e-05	0.0002	CcSEcCtD
Epoprostenol—Anxiety—Prednisone—asthma	7e-05	0.000199	CcSEcCtD
Epoprostenol—Insomnia—Betamethasone—asthma	6.99e-05	0.000199	CcSEcCtD
Epoprostenol—Insomnia—Dexamethasone—asthma	6.99e-05	0.000199	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	6.97e-05	0.000199	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Methylprednisolone—asthma	6.95e-05	0.000198	CcSEcCtD
Epoprostenol—Paraesthesia—Betamethasone—asthma	6.94e-05	0.000198	CcSEcCtD
Epoprostenol—Paraesthesia—Dexamethasone—asthma	6.94e-05	0.000198	CcSEcCtD
Epoprostenol—Hypersensitivity—Prednisolone—asthma	6.83e-05	0.000194	CcSEcCtD
Epoprostenol—Dyspepsia—Betamethasone—asthma	6.8e-05	0.000194	CcSEcCtD
Epoprostenol—Dyspepsia—Dexamethasone—asthma	6.8e-05	0.000194	CcSEcCtD
Epoprostenol—Urticaria—Triamcinolone—asthma	6.77e-05	0.000193	CcSEcCtD
Epoprostenol—Urticaria—Methylprednisolone—asthma	6.75e-05	0.000192	CcSEcCtD
Epoprostenol—Body temperature increased—Triamcinolone—asthma	6.73e-05	0.000192	CcSEcCtD
Epoprostenol—Oedema—Prednisone—asthma	6.73e-05	0.000192	CcSEcCtD
Epoprostenol—Anaphylactic shock—Prednisone—asthma	6.73e-05	0.000192	CcSEcCtD
Epoprostenol—Abdominal pain—Methylprednisolone—asthma	6.72e-05	0.000191	CcSEcCtD
Epoprostenol—Decreased appetite—Dexamethasone—asthma	6.72e-05	0.000191	CcSEcCtD
Epoprostenol—Decreased appetite—Betamethasone—asthma	6.72e-05	0.000191	CcSEcCtD
Epoprostenol—Infection—Prednisone—asthma	6.69e-05	0.00019	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Betamethasone—asthma	6.67e-05	0.00019	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Dexamethasone—asthma	6.67e-05	0.00019	CcSEcCtD
Epoprostenol—Hypersensitivity—Hydrocortisone—asthma	6.67e-05	0.00019	CcSEcCtD
Epoprostenol—Fatigue—Dexamethasone—asthma	6.66e-05	0.00019	CcSEcCtD
Epoprostenol—Fatigue—Betamethasone—asthma	6.66e-05	0.00019	CcSEcCtD
Epoprostenol—Shock—Prednisone—asthma	6.62e-05	0.000189	CcSEcCtD
Epoprostenol—Pain—Dexamethasone—asthma	6.61e-05	0.000188	CcSEcCtD
Epoprostenol—Pain—Betamethasone—asthma	6.61e-05	0.000188	CcSEcCtD
Epoprostenol—Nervous system disorder—Prednisone—asthma	6.6e-05	0.000188	CcSEcCtD
Epoprostenol—Tachycardia—Prednisone—asthma	6.57e-05	0.000187	CcSEcCtD
Epoprostenol—Skin disorder—Prednisone—asthma	6.54e-05	0.000186	CcSEcCtD
Epoprostenol—Hyperhidrosis—Prednisone—asthma	6.51e-05	0.000185	CcSEcCtD
Epoprostenol—Asthenia—Hydrocortisone—asthma	6.49e-05	0.000185	CcSEcCtD
Epoprostenol—Anorexia—Prednisone—asthma	6.42e-05	0.000183	CcSEcCtD
Epoprostenol—Pruritus—Hydrocortisone—asthma	6.4e-05	0.000182	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Dexamethasone—asthma	6.32e-05	0.00018	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Betamethasone—asthma	6.32e-05	0.00018	CcSEcCtD
Epoprostenol—Hypersensitivity—Triamcinolone—asthma	6.28e-05	0.000179	CcSEcCtD
Epoprostenol—Hypersensitivity—Methylprednisolone—asthma	6.26e-05	0.000178	CcSEcCtD
Epoprostenol—Diarrhoea—Hydrocortisone—asthma	6.19e-05	0.000176	CcSEcCtD
Epoprostenol—Urticaria—Dexamethasone—asthma	6.14e-05	0.000175	CcSEcCtD
Epoprostenol—Urticaria—Betamethasone—asthma	6.14e-05	0.000175	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Prednisone—asthma	6.13e-05	0.000175	CcSEcCtD
Epoprostenol—Dizziness—Prednisolone—asthma	6.13e-05	0.000174	CcSEcCtD
Epoprostenol—Asthenia—Triamcinolone—asthma	6.11e-05	0.000174	CcSEcCtD
Epoprostenol—Body temperature increased—Betamethasone—asthma	6.11e-05	0.000174	CcSEcCtD
Epoprostenol—Abdominal pain—Betamethasone—asthma	6.11e-05	0.000174	CcSEcCtD
Epoprostenol—Body temperature increased—Dexamethasone—asthma	6.11e-05	0.000174	CcSEcCtD
Epoprostenol—Abdominal pain—Dexamethasone—asthma	6.11e-05	0.000174	CcSEcCtD
Epoprostenol—Asthenia—Methylprednisolone—asthma	6.1e-05	0.000174	CcSEcCtD
Epoprostenol—Insomnia—Prednisone—asthma	6.09e-05	0.000173	CcSEcCtD
Epoprostenol—Paraesthesia—Prednisone—asthma	6.05e-05	0.000172	CcSEcCtD
Epoprostenol—Pruritus—Triamcinolone—asthma	6.03e-05	0.000172	CcSEcCtD
Epoprostenol—Pruritus—Methylprednisolone—asthma	6.01e-05	0.000171	CcSEcCtD
Epoprostenol—Dizziness—Hydrocortisone—asthma	5.98e-05	0.00017	CcSEcCtD
Epoprostenol—Dyspepsia—Prednisone—asthma	5.93e-05	0.000169	CcSEcCtD
Epoprostenol—Decreased appetite—Prednisone—asthma	5.85e-05	0.000167	CcSEcCtD
Epoprostenol—Rash—Prednisolone—asthma	5.84e-05	0.000166	CcSEcCtD
Epoprostenol—Dermatitis—Prednisolone—asthma	5.84e-05	0.000166	CcSEcCtD
Epoprostenol—Diarrhoea—Methylprednisolone—asthma	5.82e-05	0.000166	CcSEcCtD
Epoprostenol—Fatigue—Prednisone—asthma	5.8e-05	0.000165	CcSEcCtD
Epoprostenol—Headache—Prednisolone—asthma	5.8e-05	0.000165	CcSEcCtD
Epoprostenol—Constipation—Prednisone—asthma	5.76e-05	0.000164	CcSEcCtD
Epoprostenol—Vomiting—Hydrocortisone—asthma	5.75e-05	0.000164	CcSEcCtD
Epoprostenol—Rash—Hydrocortisone—asthma	5.7e-05	0.000162	CcSEcCtD
Epoprostenol—Dermatitis—Hydrocortisone—asthma	5.7e-05	0.000162	CcSEcCtD
Epoprostenol—Headache—Hydrocortisone—asthma	5.67e-05	0.000161	CcSEcCtD
Epoprostenol—Dizziness—Triamcinolone—asthma	5.63e-05	0.00016	CcSEcCtD
Epoprostenol—Dizziness—Methylprednisolone—asthma	5.62e-05	0.00016	CcSEcCtD
Epoprostenol—Asthenia—Dexamethasone—asthma	5.55e-05	0.000158	CcSEcCtD
Epoprostenol—Asthenia—Betamethasone—asthma	5.55e-05	0.000158	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Prednisone—asthma	5.5e-05	0.000157	CcSEcCtD
Epoprostenol—Nausea—Prednisolone—asthma	5.5e-05	0.000157	CcSEcCtD
Epoprostenol—Pruritus—Dexamethasone—asthma	5.47e-05	0.000156	CcSEcCtD
Epoprostenol—Pruritus—Betamethasone—asthma	5.47e-05	0.000156	CcSEcCtD
Epoprostenol—Vomiting—Triamcinolone—asthma	5.42e-05	0.000154	CcSEcCtD
Epoprostenol—Vomiting—Methylprednisolone—asthma	5.4e-05	0.000154	CcSEcCtD
Epoprostenol—Nausea—Hydrocortisone—asthma	5.37e-05	0.000153	CcSEcCtD
Epoprostenol—Rash—Triamcinolone—asthma	5.37e-05	0.000153	CcSEcCtD
Epoprostenol—Dermatitis—Triamcinolone—asthma	5.37e-05	0.000153	CcSEcCtD
Epoprostenol—Rash—Methylprednisolone—asthma	5.36e-05	0.000153	CcSEcCtD
Epoprostenol—Dermatitis—Methylprednisolone—asthma	5.35e-05	0.000152	CcSEcCtD
Epoprostenol—Urticaria—Prednisone—asthma	5.35e-05	0.000152	CcSEcCtD
Epoprostenol—Headache—Triamcinolone—asthma	5.34e-05	0.000152	CcSEcCtD
Epoprostenol—Headache—Methylprednisolone—asthma	5.33e-05	0.000152	CcSEcCtD
Epoprostenol—Abdominal pain—Prednisone—asthma	5.32e-05	0.000152	CcSEcCtD
Epoprostenol—Body temperature increased—Prednisone—asthma	5.32e-05	0.000152	CcSEcCtD
Epoprostenol—Diarrhoea—Betamethasone—asthma	5.29e-05	0.000151	CcSEcCtD
Epoprostenol—Diarrhoea—Dexamethasone—asthma	5.29e-05	0.000151	CcSEcCtD
Epoprostenol—Dizziness—Dexamethasone—asthma	5.11e-05	0.000146	CcSEcCtD
Epoprostenol—Dizziness—Betamethasone—asthma	5.11e-05	0.000146	CcSEcCtD
Epoprostenol—Nausea—Triamcinolone—asthma	5.06e-05	0.000144	CcSEcCtD
Epoprostenol—Nausea—Methylprednisolone—asthma	5.05e-05	0.000144	CcSEcCtD
Epoprostenol—Hypersensitivity—Prednisone—asthma	4.96e-05	0.000141	CcSEcCtD
Epoprostenol—Vomiting—Betamethasone—asthma	4.92e-05	0.00014	CcSEcCtD
Epoprostenol—Vomiting—Dexamethasone—asthma	4.92e-05	0.00014	CcSEcCtD
Epoprostenol—Rash—Dexamethasone—asthma	4.87e-05	0.000139	CcSEcCtD
Epoprostenol—Rash—Betamethasone—asthma	4.87e-05	0.000139	CcSEcCtD
Epoprostenol—Dermatitis—Betamethasone—asthma	4.87e-05	0.000139	CcSEcCtD
Epoprostenol—Dermatitis—Dexamethasone—asthma	4.87e-05	0.000139	CcSEcCtD
Epoprostenol—Headache—Betamethasone—asthma	4.84e-05	0.000138	CcSEcCtD
Epoprostenol—Headache—Dexamethasone—asthma	4.84e-05	0.000138	CcSEcCtD
Epoprostenol—Asthenia—Prednisone—asthma	4.83e-05	0.000138	CcSEcCtD
Epoprostenol—Pruritus—Prednisone—asthma	4.76e-05	0.000136	CcSEcCtD
Epoprostenol—Diarrhoea—Prednisone—asthma	4.61e-05	0.000131	CcSEcCtD
Epoprostenol—Nausea—Betamethasone—asthma	4.59e-05	0.000131	CcSEcCtD
Epoprostenol—Nausea—Dexamethasone—asthma	4.59e-05	0.000131	CcSEcCtD
Epoprostenol—Dizziness—Prednisone—asthma	4.45e-05	0.000127	CcSEcCtD
Epoprostenol—Vomiting—Prednisone—asthma	4.28e-05	0.000122	CcSEcCtD
Epoprostenol—PTGER1—Signaling Pathways—CCR3—asthma	4.27e-05	0.000155	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—C3—asthma	4.27e-05	0.000154	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—C3—asthma	4.27e-05	0.000154	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—IL2RA—asthma	4.25e-05	0.000154	CbGpPWpGaD
Epoprostenol—Rash—Prednisone—asthma	4.24e-05	0.000121	CcSEcCtD
Epoprostenol—Dermatitis—Prednisone—asthma	4.24e-05	0.000121	CcSEcCtD
Epoprostenol—PTGIS—Metabolism—PLA2G4A—asthma	4.23e-05	0.000153	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—GSTM1—asthma	4.23e-05	0.000153	CbGpPWpGaD
Epoprostenol—Headache—Prednisone—asthma	4.22e-05	0.00012	CcSEcCtD
Epoprostenol—P2RY12—Signaling by GPCR—C3—asthma	4.21e-05	0.000152	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—EDNRB—asthma	4.18e-05	0.000151	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NPY—asthma	4.17e-05	0.000151	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NPY—asthma	4.17e-05	0.000151	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NPS—asthma	4.14e-05	0.00015	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TAC1—asthma	4.14e-05	0.00015	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CXCR3—asthma	4.06e-05	0.000147	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—PPP2CA—asthma	4.04e-05	0.000146	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—PPP2CA—asthma	4.04e-05	0.000146	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—AGTR2—asthma	4.02e-05	0.000145	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—AGTR2—asthma	4.02e-05	0.000145	CbGpPWpGaD
Epoprostenol—Nausea—Prednisone—asthma	4e-05	0.000114	CcSEcCtD
Epoprostenol—CYP2C9—Biological oxidations—GSTM1—asthma	4e-05	0.000145	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—IL2—asthma	3.99e-05	0.000144	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CCR5—asthma	3.97e-05	0.000143	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CCR5—asthma	3.97e-05	0.000143	CbGpPWpGaD
Epoprostenol—CYP2C9—Metapathway biotransformation—GSTM1—asthma	3.94e-05	0.000143	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CYBA—asthma	3.93e-05	0.000142	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—IL2RA—asthma	3.91e-05	0.000141	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—IL2RA—asthma	3.91e-05	0.000141	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PPP2CA—asthma	3.9e-05	0.000141	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—C3—asthma	3.87e-05	0.00014	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—C3—asthma	3.87e-05	0.00014	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—NOS2—asthma	3.87e-05	0.00014	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PARP1—asthma	3.85e-05	0.000139	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IL5—asthma	3.85e-05	0.000139	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—EDNRB—asthma	3.85e-05	0.000139	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—EDNRB—asthma	3.85e-05	0.000139	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TAC1—asthma	3.81e-05	0.000138	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NPS—asthma	3.81e-05	0.000138	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TAC1—asthma	3.81e-05	0.000138	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NPS—asthma	3.81e-05	0.000138	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CXCR3—asthma	3.74e-05	0.000135	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CXCR3—asthma	3.74e-05	0.000135	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—BDKRB2—asthma	3.71e-05	0.000134	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—POMC—asthma	3.71e-05	0.000134	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—VEGFA—asthma	3.69e-05	0.000133	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CYBA—asthma	3.62e-05	0.000131	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CYBA—asthma	3.62e-05	0.000131	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—ADCY2—asthma	3.59e-05	0.00013	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IL3—asthma	3.58e-05	0.00013	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PARP1—asthma	3.54e-05	0.000128	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PARP1—asthma	3.54e-05	0.000128	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IL5—asthma	3.54e-05	0.000128	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IL5—asthma	3.54e-05	0.000128	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—IL6R—asthma	3.48e-05	0.000126	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—BDKRB2—asthma	3.42e-05	0.000124	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—BDKRB2—asthma	3.42e-05	0.000124	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—POMC—asthma	3.41e-05	0.000123	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—POMC—asthma	3.41e-05	0.000123	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—VEGFA—asthma	3.39e-05	0.000123	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—TGFB1—asthma	3.38e-05	0.000122	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—KNG1—asthma	3.38e-05	0.000122	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—POMC—asthma	3.37e-05	0.000122	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—AGTR1—asthma	3.36e-05	0.000122	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—ADCY2—asthma	3.31e-05	0.00012	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—ADCY2—asthma	3.31e-05	0.00012	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IL3—asthma	3.3e-05	0.000119	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IL3—asthma	3.3e-05	0.000119	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CCL2—asthma	3.29e-05	0.000119	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—IL6R—asthma	3.28e-05	0.000119	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CXCL10—asthma	3.28e-05	0.000119	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—RHOA—asthma	3.27e-05	0.000118	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—SERPINE1—asthma	3.26e-05	0.000118	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—asthma	3.26e-05	0.000118	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	3.26e-05	0.000118	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NTRK1—asthma	3.22e-05	0.000117	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—ADRB2—asthma	3.19e-05	0.000115	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—RHOA—asthma	3.15e-05	0.000114	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—NOS3—asthma	3.11e-05	0.000113	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—TGFB1—asthma	3.11e-05	0.000113	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—KNG1—asthma	3.11e-05	0.000113	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—KNG1—asthma	3.11e-05	0.000113	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—asthma	3.11e-05	0.000112	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—POMC—asthma	3.1e-05	0.000112	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—POMC—asthma	3.1e-05	0.000112	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—AGTR1—asthma	3.09e-05	0.000112	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—AGTR1—asthma	3.09e-05	0.000112	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CCL2—asthma	3.03e-05	0.00011	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CCL2—asthma	3.03e-05	0.00011	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—IL6R—asthma	3.02e-05	0.000109	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—IL6R—asthma	3.02e-05	0.000109	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CXCL10—asthma	3.02e-05	0.000109	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CXCL10—asthma	3.02e-05	0.000109	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—ITPR1—asthma	3.01e-05	0.000109	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—RHOA—asthma	3.01e-05	0.000109	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—RHOA—asthma	3.01e-05	0.000109	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—POMC—asthma	2.99e-05	0.000108	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—RHOA—asthma	2.97e-05	0.000107	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NTRK1—asthma	2.96e-05	0.000107	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NTRK1—asthma	2.96e-05	0.000107	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—ADRB2—asthma	2.93e-05	0.000106	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—ADRB2—asthma	2.93e-05	0.000106	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CD86—asthma	2.87e-05	0.000104	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—CD4—asthma	2.87e-05	0.000104	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—CXCL8—asthma	2.87e-05	0.000104	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—PTGS2—asthma	2.85e-05	0.000103	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—EDN1—asthma	2.85e-05	0.000103	CbGpPWpGaD
Epoprostenol—CYP2C9—Biological oxidations—POMC—asthma	2.83e-05	0.000102	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CCL5—asthma	2.83e-05	0.000102	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PLA2G4A—asthma	2.81e-05	0.000102	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CSF2—asthma	2.78e-05	0.000101	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—ITPR1—asthma	2.77e-05	0.0001	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—ITPR1—asthma	2.77e-05	0.0001	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—asthma	2.77e-05	0.0001	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—IL2—asthma	2.74e-05	9.92e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—RHOA—asthma	2.73e-05	9.88e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—RHOA—asthma	2.73e-05	9.88e-05	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—ALB—asthma	2.73e-05	9.87e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—SMAD3—asthma	2.71e-05	9.8e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—LTC4S—asthma	2.67e-05	9.65e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—asthma	2.64e-05	9.57e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CD86—asthma	2.64e-05	9.56e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CD86—asthma	2.64e-05	9.56e-05	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—CXCL8—asthma	2.64e-05	9.55e-05	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—CXCL8—asthma	2.64e-05	9.55e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—EDN1—asthma	2.62e-05	9.48e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—EDN1—asthma	2.62e-05	9.48e-05	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—NOS3—asthma	2.61e-05	9.44e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CXCL8—asthma	2.6e-05	9.43e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CCL5—asthma	2.6e-05	9.41e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CCL5—asthma	2.6e-05	9.41e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PPP2CA—asthma	2.59e-05	9.38e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PLA2G4A—asthma	2.59e-05	9.37e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PLA2G4A—asthma	2.59e-05	9.37e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CSF2—asthma	2.56e-05	9.27e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CSF2—asthma	2.56e-05	9.27e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CCR5—asthma	2.55e-05	9.21e-05	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—IL2—asthma	2.52e-05	9.13e-05	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—IL2—asthma	2.52e-05	9.13e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IL2RA—asthma	2.51e-05	9.08e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—SMAD3—asthma	2.49e-05	9.02e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—SMAD3—asthma	2.49e-05	9.02e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—IL2—asthma	2.49e-05	9.01e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—C3—asthma	2.49e-05	9e-05	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—PTEN—asthma	2.48e-05	8.99e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PDGFB—asthma	2.42e-05	8.76e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CXCL8—asthma	2.4e-05	8.67e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CXCL8—asthma	2.4e-05	8.67e-05	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PTGS2—asthma	2.39e-05	8.63e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PPP2CA—asthma	2.39e-05	8.63e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PPP2CA—asthma	2.39e-05	8.63e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CCR5—asthma	2.34e-05	8.48e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CCR5—asthma	2.34e-05	8.48e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—LEP—asthma	2.32e-05	8.38e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—LTA4H—asthma	2.31e-05	8.36e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IL2RA—asthma	2.31e-05	8.35e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IL2RA—asthma	2.31e-05	8.35e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—IL2—asthma	2.29e-05	8.29e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—IL2—asthma	2.29e-05	8.29e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—C3—asthma	2.29e-05	8.28e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—C3—asthma	2.29e-05	8.28e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PDGFB—asthma	2.23e-05	8.06e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PDGFB—asthma	2.23e-05	8.06e-05	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—STAT3—asthma	2.22e-05	8.04e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—FN1—asthma	2.18e-05	7.9e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—LEP—asthma	2.13e-05	7.71e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—LEP—asthma	2.13e-05	7.71e-05	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PTEN—asthma	2.08e-05	7.53e-05	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—TGFB1—asthma	2.06e-05	7.45e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ARG1—asthma	2.02e-05	7.31e-05	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—EGFR—asthma	2.02e-05	7.31e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—FN1—asthma	2.01e-05	7.27e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—FN1—asthma	2.01e-05	7.27e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—POMC—asthma	1.99e-05	7.2e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CCL2—asthma	1.95e-05	7.04e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IL6R—asthma	1.94e-05	7.02e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—EGFR—asthma	1.9e-05	6.89e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—POMC—asthma	1.83e-05	6.62e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—POMC—asthma	1.83e-05	6.62e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ALDH7A1—asthma	1.83e-05	6.61e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—SERPINE1—asthma	1.82e-05	6.57e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CCL2—asthma	1.79e-05	6.48e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CCL2—asthma	1.79e-05	6.48e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IL6R—asthma	1.79e-05	6.46e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IL6R—asthma	1.79e-05	6.46e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—RHOA—asthma	1.75e-05	6.34e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—EGFR—asthma	1.75e-05	6.34e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—EGFR—asthma	1.75e-05	6.34e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ARG2—asthma	1.75e-05	6.34e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NOS3—asthma	1.73e-05	6.28e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—SERPINE1—asthma	1.67e-05	6.05e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—SERPINE1—asthma	1.67e-05	6.05e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—RHOA—asthma	1.61e-05	5.84e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—RHOA—asthma	1.61e-05	5.84e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NOS3—asthma	1.6e-05	5.78e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NOS3—asthma	1.6e-05	5.78e-05	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—IL6—asthma	1.55e-05	5.62e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CXCL8—asthma	1.54e-05	5.57e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	1.54e-05	5.56e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IL2—asthma	1.47e-05	5.32e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—IL6—asthma	1.46e-05	5.29e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ALOX5AP—asthma	1.45e-05	5.25e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ALOX15—asthma	1.45e-05	5.25e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CXCL8—asthma	1.42e-05	5.12e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CXCL8—asthma	1.42e-05	5.12e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MMP9—asthma	1.39e-05	5.04e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CHAT—asthma	1.38e-05	5.01e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PTEN—asthma	1.38e-05	5.01e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IL2—asthma	1.35e-05	4.9e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IL2—asthma	1.35e-05	4.9e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—IL6—asthma	1.35e-05	4.87e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—IL6—asthma	1.35e-05	4.87e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MMP9—asthma	1.28e-05	4.63e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MMP9—asthma	1.28e-05	4.63e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PTEN—asthma	1.27e-05	4.61e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PTEN—asthma	1.27e-05	4.61e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—VEGFA—asthma	1.25e-05	4.52e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—STAT3—asthma	1.24e-05	4.48e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ALOX5—asthma	1.23e-05	4.47e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CARM1—asthma	1.18e-05	4.26e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—DCN—asthma	1.16e-05	4.2e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—VEGFA—asthma	1.15e-05	4.16e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—VEGFA—asthma	1.15e-05	4.16e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TGFB1—asthma	1.15e-05	4.15e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—STAT3—asthma	1.14e-05	4.12e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—STAT3—asthma	1.14e-05	4.12e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ALDH2—asthma	1.13e-05	4.08e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—EGFR—asthma	1.12e-05	4.07e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—asthma	1.09e-05	3.93e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GSTT1—asthma	1.07e-05	3.88e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TGFB1—asthma	1.06e-05	3.82e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TGFB1—asthma	1.06e-05	3.82e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—EGFR—asthma	1.04e-05	3.75e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—EGFR—asthma	1.04e-05	3.75e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—asthma	9.89e-06	3.58e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—NQO1—asthma	8.92e-06	3.23e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ADCY2—asthma	8.73e-06	3.16e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—asthma	8.66e-06	3.13e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IL6—asthma	8.64e-06	3.13e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IL6—asthma	7.95e-06	2.88e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IL6—asthma	7.95e-06	2.88e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—asthma	7.55e-06	2.73e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GSTP1—asthma	7.44e-06	2.69e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—HMOX1—asthma	7.34e-06	2.66e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ITPR1—asthma	7.32e-06	2.65e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CAT—asthma	7.24e-06	2.62e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GSTM1—asthma	6.84e-06	2.47e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PLA2G4A—asthma	6.84e-06	2.47e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PPP2CA—asthma	6.3e-06	2.28e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—POMC—asthma	4.83e-06	1.75e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ALB—asthma	4.41e-06	1.59e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—NOS3—asthma	4.22e-06	1.53e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PTGS2—asthma	3.86e-06	1.39e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PTEN—asthma	3.36e-06	1.22e-05	CbGpPWpGaD
